UsAgainstAlzheimer’s Launches Brain Health Academy
The Brain Health Academy offers free, evidence-based courses for health and wellness professionals about how to help people reduce their risk of dementia and Alzheimer’s
A-LIST Pulse of the Community, Volume 11, May 2022
The mission of the UsAgainstAlzheimer’s A-LIST® is to use survey results to make life better for the broader Alzheimer’s and dementia community.
Say Hello to BrainGuide
Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.
New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments
A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials.
UsAgainstAlzheimer’s Launches Brain Health Academy
A-LIST Pulse of the Community, Volume 11, May 2022
Say Hello to BrainGuide
Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

UsAgainstAlzheimer's: Working to End Alzheimer's Disease
The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.
UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.
We bring all of “Us” together to:
- Improve brain health and promote earlier detection, diagnosis and intervention
- Champion health equity and access for communities of color and women who are disproportionately impacted by the disease
- Advocate for increased research spending that will speed treatments to market
- Drive changes that matter most to people living with the disease and caregivers
In the past decade, progress has been made, with more hope on the horizon now than ever before.
But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.